Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease

Journal of Alzheimer's Disease

Volumn 9, Issue 2, 2006, Pages 147-153

  Zhu, Xiongwei ^a   Perry, George ^a   Moreira, Paula I ^a,b   Aliev, Gjumrakch ^a   Cash, Adam D ^a   Hirai, Keisuke ^c   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

Author keywords

Alzheimer disease; Cell cycle re entry; Mitochondria; Mitochondrial transport; Mitochondrial turnover; Oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; ANTIINFLAMMATORY AGENT; CYTOCHROME C OXIDASE; FREE RADICAL; MITOCHONDRIAL DNA; OXYGEN RADICAL; SELEGILINE;

ALZHEIMER DISEASE; BRAIN; CELL CYCLE; CELL ORGANELLE; CELL TRANSPORT; CHROMOSOME CONDENSATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GENE DELETION; GENETIC MARKER; HUMAN; INFLAMMATION; METABOLIC DISORDER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 33746089859     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9207     Document Type: Review

References (75)

1. T. Arendt, L. Rodel, U. Gartner and M. Holzer, Expression of the cyclin-dependent kinase inhibitor p16 in Alzheimer's disease, Neuroreport 7 (1996), 3047-3049.
2. S. Barni, L. Sciola, A. Spano and P. Pippia, Static cytofluorometry and fluorescence morphology of mitochondria and DNA in proliferating fibroblasts, Biotech Histochem 71 (1996), 66-70.
3. C. Behl, J. Davis, G.M. Cole and D. Schubert, Vitamin E protects nerve cells from amyloid beta protein toxicity, Biochem Biophys Res Commun 186 (1992), 944-950.
4. C. Behl, J.B. Davis, R. Lesley and D. Schubert, Hydrogen peroxide mediates amyloid beta protein toxicity, Cell 77 (1994), 817-827.
5. J.P. Blass, The mitochondrial spiral. An adequate cause of dementia in the Alzheimer's syndrome, Ann N Y Acad Sci 924 (2000), 170-183.
6. A.C. Bowling and M.F. Beal, Bioenergetic and oxidative stress in neurodegenerative diseases, Life Sci 56 (1995), 1151-1171.
7. J.C. Breitner, The role of anti-inflammatory drugs in the prevention and treatment of Alzheimer's disease, Annu Rev Med 47 (1996), 401-411.
8. P. Bubber, V. Haroutunian, G. Fisch, J.P. Blass and G.E. Gibson, Mitochondrial abnormalities in Alzheimer brain: mechanistic implications, Ann Neurol 57 (2005), 695-703.
9. A.D. Cash, G. Aliev, S.L. Siedlak, A. Nunomura, H. Fujioka, X. Zhu, A.K. Raina, H.V. Vinters, M. Tabaton, A.B. Johnson, M. Paula-Barbosa, J. Avila, P.K. Jones, R.J. Castellani, M.A. Smith and G. Perry, Microtubule reduction in Alzheimer's disease and aging is independent of tau filament formation, Am J Pathol 162 (2003), 1623-1627.
10. A.M. Cataldo, J.L. Barnett, S.A. Berman, J. Li, S. Quarless, S. Bursztajn, C. Lippa and R.A. Nixon, Gene expression and cellular content of cathepsin D in Alzheimer's disease brain: evidence for early up-regulation of the endosomal-lysosomal system, Neuron 14 (1995), 671-680.
11. A.M. Cataldo, C.M. Peterhoff, J.C. Troncoso, T. Gomez-Isla, B.T. Hyman and R.A. Nixon, Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations, Am J Pathol 157 (2000), 277-286.
12. P.E. Coskun, M.F. Beal and D.C. Wallace, Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication, Proc Natl Acad Sci U S A 101 (2004), 10726-10731.
13. J.W. Crabb, J. O'Neil, M. Miyagi, K. West and H.F. Hoff, Hydroxynonenal inactivates cathepsin B by forming Michael adducts with active site residues, Protein Sci 11 (2002), 831-840.
14. D.C. David, S. Hauptmann, I. Scherping, K. Schuessel, U. Keil, P. Rizzu, R. Ravid, S. Drose, U. Brandt, W.E. Muller, A. Eckert and J. Gotz, Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice, J Biol Chem 280 (2005), 23802-23814.
15. M.E. De Leo, S. Borrello, M. Passantino, B. Palazzotti, A. Mordente, A. Daniele, V. Filippini, T. Galeotti and C. Masullo, Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease, Neurosci Lett 250 (1998), 173-176.
16. S.T. DeKosky, S.W. Scheff and S.D. Styren, Structural correlates of cognition in dementia: quantification and assessment of synapse change, Neurodegeneration 5 (1996), 417-421.
17. J.P. Eiserich, A.G. Estevez, T.V. Bamberg, Y.Z. Ye, P.H. Chumley, J.S. Beckman and B.A. Freeman, Microtubule dysfunction by posttranslational nitrotyrosination of alpha-tubulin: a nitric oxide-dependent mechanism of cellular injury, Proc Natl Acad Sci USA 96 (1999), 6365-6370.
18. B. Friguet, E.R. Stadtman and L.I. Szweda, Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease, J Biol Chem 269 (1994), 21639-21643.
19. U. Gartner, M. Holzer and T. Arendt, Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration, Neuroscience 91 (1999), 1-5.
20. G.E. Gibson, K.F. Sheu and J.P. Blass, Abnormalities of mitochondrial enzymes in Alzheimer disease, J Neural Transm 105 (1998), 855-870.
21. C.A. Hansson, S. Frykman, M.R. Farmery, L.O. Tjernberg, C. Nilsberth, S.E. Pursglove, A. Ito, B. Winblad, R.F. Cowburn, J. Thyberg and M. Ankarcrona, Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria, J Biol Chem 279 (2004), 51654-51660.
22. P.L. Harris, X. Zhu, C. Pamies, C.A. Rottkamp, H.A. Ghanbari, A. McShea, Y. Feng, D.K. Ferris and M.A. Smith, Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes, Neurobiol Aging 21 (2000), 837-841.
23. N. Hattori, K. Kitagawa, T. Higashida, K. Yagyu, S. Shimohama, T. Wataya, G. Perry, M.A. Smith and C. Inagaki, CI-ATPase and Na+/K(+)-ATPase activities in Alzheimer's disease brains, Neurosci Lett 254 (1998), 141-144.
24. K. Hirai, G. Aliev, A. Nunomura, H. Fujioka, R.L. Russell, C.S. Atwood, A.B. Johnson, Y. Kress, H.V. Vinters, M. Tabaton, S. Shimohama, A.D. Cash, S.L. Siedlak, P.L. Harris, P.K. Jones, R.B. Petersen, G. Perry and M.A. Smith, Mitochondrial abnormalities in Alzheimer's disease, J Neurosci 21 (2001), 3017-3023.
25. K.M. Humphries and L.I. Szweda, Selective inactivation of alpha-ketoglutarate dehydrogenase and pyruvate dehydrogenase: reaction of lipoic acid with 4-hydroxy-2-nonenal, Biochemistry 37 (1998), 15835-15841.
26. K. Iqbal, C. Alonso Adel, E. El-Akkad, C.X. Gong, N. Haque, S. Khatoon, J.J. Pei, H. Tanimukai, I. Tsujio, J.Z. Wang and I. Grundke-Iqba, Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays, J Mol Neurosci 20 (2003), 425-430.
27. J.N. Keller, K.B. Hanni and W.R. Markesbery, Impaired proteasome function in Alzheimer's disease, J Neurochem 75 (2000), 436-439.
28. J.N. Keller, F.F. Huang and W.R. Markesbery, Decreased levels of proteasome activity and proteasome expression in aging spinal cord, Neuroscience 98 (2000), 149-156.
29. S.M. Khan, D.S. Cassarino, N.N. Abramova, P.M. Keeney, M.K. Borland, P.A. Trimmer, C.T. Krebs, J.C. Bennett, J.K. Parks, R.H. Swerdlow, W.D. Parker, Jr. and J.P. Bennett, Jr., Alzheimer's disease cybrids replicate beta-amyloid abnormalities through cell death pathways, Ann Neurol 48 (2000), 148-155.
30. Q. Liu, M.A. Smith, J. Avila, J. DeBernardis, M. Kansal, A. Takeda, X. Zhu, A. Nunomura, K. Honda, P.I. Moreira, C.R. Oliveira, M.S. Santos, S. Shimohama, G. Aliev, J. de la Torre, H.A. Ghanbari, S.L. Siedlak, P.L. Harris, L.M. Sayre and G. Perry, Alzheimer-specific epitopes of tau represent lipid peroxidation-induced conformations, Free Radic Biol Med 38 (2005), 746-754.
31. T.D. Lockwood, Inactivation of intracellular proteolysis and cathepsin B enzyme activity by dehydroascorbic acid and reactivation by dithiothreitol in perfused rat heart, Biochem Pharmacol 54 (1997), 669-675.
32. M.A. Lovell, W.D. Ehmann, S.M. Butler and W.R. Markesbery, Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease, Neurology 45 (1995), 1594-1601.
33. Y. Luo, J.D. Bond and V.M. Ingram, Compromised mitochondrial function leads to increased cytosolic calcium and to activation of MAP kinases, Proc Natl Acad Sci USA 94 (1997), 9705-9710.
34. J.W. Lustbader, M. Cirilli, C. Lin, H.W. Xu, K. Takuma, N. Wang, C. Caspersen, X. Chen, S. Pollak, M. Chaney, F. Trinchese, S. Liu, F. Gunn-Moore, L.F. Lue, D.G. Walker, P. Kuppusamy, Z.L. Zewier, O. Arancio, D. Stern, S.S. Yan and H. Wu, ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease, Science 304 (2004), 448-452.
35. J.L. Marcum, J.K. Mathenia, R. Chan and R.P. Guttmann, Oxidation of thiol-proteases in the hippocampus of Alzheimer's disease, Biochem Biophys Res Commun 334 (2005), 342-348.
36. M. Marlatt, H.G. Lee, G. Perry, M.A. Smith and X. Zhu, Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease, Acta Neurobiol Exp (Wars) 64 (2004), 81-87.
37. R.N. Martins, C.G. Harper, G.B. Stokes and C.L. Masters, Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress, J Neurochem 46 (1986), 1042-1045.
38. E. Masliah and R. Terry, The role of synaptic proteins in the pathogenesis of disorders of the central nervous system, Brain Pathol 3 (1993), 77-85.
39. P.M. Mathews, C.B. Guerra, Y. Jiang, O.M. Grbovic, B.H. Kao, S.D. Schmidt, R. Dinakar, M. Mercken, A. Hille-Rehfeld, J. Rohrer, P. Mehta, A.M. Cataldo and R.A. Nixon, Alzheimer's disease-related overexpression of the cation-dependent mannose 6-phosphate receptor increases Abeta secretion: role for altered lysosomal hydrolase distribution in beta-amyloidogenesis, J Biol Chem 277 (2002), 5299-5307.
40. A. McShea, P.L. Harris, K.R. Webster, A.F. Wahl and M.A. Smith, Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease, Am J Pathol 150 (1997), 1933-1939.
41. A. McShea, A.F. Wahl and M.A. Smith, Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease, Med Hypotheses 52 (1999), 525-527.
42. H. Mori, J. Kondo and Y. Ihara, Ubiquitin is a component of paired helical filaments in Alzheimer's disease, Science 235 (1987), 1641-1644.
43. Z. Nagy, M.M. Esiri, A.M. Cato and A.D. Smith, Cell cycle markers in the hippocampus in Alzheimer's disease, Acta Neuropathol (Berl) 94 (1997), 6-15.
44. Z. Nagy, M.M. Esiri and A.D. Smith, Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditions, Acta Neuropathol (Berl) 93 (1997), 294-300.
45. R.A. Nixon, J. Wegiel, A. Kumar, W.H. Yu, C. Peterhoff, A. Cataldo and A.M. Cuervo, Extensive involvement of autophagy in Alzheimer disease: an immuno-electron microscopy study, J Neuropathol Exp Neurol 64 (2005), 113-122.
46. G. Perry, R. Friedman, G. Shaw and V. Chau, Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains, Proc Natl Acad Sci USA 84 (1987), 3033-3036.
47. A.K. Raina, D.J. Templeton, J.C. Deak, G. Perry and M.A. Smith, Quinone reductase (NQO1), a sensitive redox indicator, is increased in Alzheimer's disease, Redox Rep 4 (1999), 23-27.
48. A.K. Raina, X. Zhu, C.A. Rottkamp, M. Monteiro, A. Takeda and M.A. Smith, Cyclin' toward dementia: cell cycle abnormalities and abortive oncogenesis in Alzheimer disease, J Neurosci Res 61 (2000), 128-133.
49. P.H. Reddy and M.F. Beal, Are mitochondria critical in the pathogenesis of Alzheimer's disease? Brain Res Brain Res Rev 49 (2005), 618-632.
50. R.L. Russell, S.L. Siedlak, A.K. Raina, J.M. Bautista, M.A. Smith and G. Perry, Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease, Arch Biochem Biophys 370 (1999), 236-239.
51. M. Sano, C. Ernesto, R.G. Thomas, M.R. Klauber, K. Schafer, M. Grundman, P. Woodbury, J. Growdon, C.W. Cotman, E. Pfeiffer, L.S. Schneider and L.J. Thal, A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study, N Engl J Med 336 (1997), 1216-1222.
52. A.A. Saraiva, M.M. Borges, M.D. Madeira, M.A. Tavares and M.M. Paula-Barbosa, Mitochondrial abnormalities in cortical dendrites from patients with Alzheimer's disease, J Submicrosc Cytol 17 (1985), 459-464.
53. L.M. Sayre, D.A. Zelasko, P.L. Harris, G. Perry, R.G. Salomon and M.A. Smith, 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease, J Neurochem 68 (1997), 2092-2097.
54. P.O. Seglen, P.E. Schwarze and G. Saeter, Changes in cellular ploidy and autophagic responsiveness during rat liver carcinogenesis, Toxicol Pathol 14 (1986), 342-348.
55. J. Shi, G. Perry, M.A. Smith and R.P. Friedland, Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease, Neurobiol Aging 21 (2000), 357-361.
56. M.A. Smith, S. Taneda, P.L. Richey, S. Miyata, S.D. Yan, D. Stern, L.M. Sayre, V.M. Monnier and G. Perry, Advanced Maillard reaction end products are associated with Alzheimer disease pathology, Proc Natl Acad Sci USA 91 (1994), 5710-5714.
57. M.A. Smith, M. Rudnicka-Nawrot, P.L. Richey, D. Praprotnik, P. Mulvihill, C.A. Miller, L.M. Sayre and G. Perry, Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease, J Neurochem 64 (1995), 2660-2666.
58. M.A. Smith, L.M. Sayre, V.M. Monnier and G. Perry, Radical AGEing in Alzheimer's disease, Trends Neurosci 18 (1995), 172-176.
59. M.A. Smith, G. Perry, P.L. Richey, L.M. Sayre, V.E. Anderson, M.F. Beal and N. Kowall, Oxidative damage in Alzheimer's, Nature 382 (1996), 120-121.
60. M.A. Smith, P.L. Harris, L.M. Sayre and G. Perry, Iron accumulation in Alzheimer disease is a source of redox-generated free radicals, Proc Natl Acad Sci USA 94 (1997), 9866-9868.
61. M.A. Smith, P.L. Richey Harris, L.M. Sayre, J.S. Beckman and G. Perry, Widespread peroxynitrite-mediated damage in Alzheimer's disease, J Neurosci 17 (1997), 2653-2657.
62. M. Sousa, A. Barros, J. Silva and J. Tesarik, Developmental changes in calcium content of ultrastructurally distinct subcellular compartments of preimplantation human embryos, Mol Hum Reprod 3 (1997), 83-90.
63. G.B. Stokin, C. Lillo, T.L. Falzone, R.G. Brusch, E. Rockenstein, S.L. Mount, R. Raman, P. Davies, E. Masliah, D.S. Williams and L.S. Goldstein, Axonopathy and transport deficits early in the pathogenesis of Alzheimer's disease, Science 307 (2005), 1282-1288.
64. A. Takeda, M.A. Smith, J. Avila, A. Nunomura, S.L. Siedlak, X. Zhu, G. Perry and L.M. Sayre, In Alzheimer's disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification, J Neurochem 75 (2000), 1234-1241.
65. P.A. Trimmer and M.K. Borland, Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement, Antioxid Redox Signal 7 (2005), 1101-1109.
66. I. Vincent, M. Rosado and P. Davies, Mitotic mechanisms in Alzheimer's disease? J Cell Biol 132 (1996), 413-425.
67. I. Vincent, G. Jicha, M. Rosado and D.W. Dickson, Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brain, J Neurosci 17 (1997), 3588-3598.
68. S.R. Vincent, M. Sebben, A. Dumuis and J. Bockaert, Neurotransmitter regulation of MAP kinase signaling in striatal neurons in primary culture, Synapse 29 (1998), 29-36.
69. W.C. Wallace, C.A. Akar, W.E. Lyons, H.K. Kole, J.M. Egan and B. Wolozin, Amyloid precursor protein requires the insulin signaling pathway for neurotrophic activity, Brain Res Mol Brain Res 52 (1997), 213-227.
70. S.D. Yan, S.F. Yan, X. Chen, J. Fu, M. Chen, P. Kuppusamy, M.A. Smith, G. Perry, G.C. Godman, P. Nawroth et al., Nonenzymatically glycated tau in Alzheimer's disease induces neuronal oxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide, Nat Med 1 (1995), 693-699.
71. X. Zhu, A.K. Raina and M.A. Smith, Cell cycle events in neurons. Proliferation or death? Am J Pathol 155 (1999), 327-329.
72. X. Zhu, C.A. Rottkamp, A.K. Raina, G.J. Brewer, H.A. Ghanbari, H. Boux and M.A. Smith, Neuronal CDK7 in hippocampus is related to aging and Alzheimer disease, Neurobiol Aging 21 (2000), 807-813.
73. X. Zhu, A.K. Raina, H.G. Lee, M. Chao, A. Nunomura, M. Tabaton, R.B. Petersen, G. Perry and M.A. Smith, Oxidative stress and neuronal adaptation in Alzheimer disease: the role of SAPK pathways, Antioxid Redox Signal 5 (2003), 571-576.
74. X. Zhu, A. McShea, P.L. Harris, A.K. Raina, R.J. Castellani, J.O. Funk, S. Shah, C. Atwood, R. Bowen, R. Bowser, L. Morelli, G. Perry and M.A. Smith, Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease, J Neurosci Res 75 (2004), 698-703.
75. X. Zhu, M.A. Smith, G. Perry and G. Aliev, Mitochondrial failures in Alzheimer's disease, Am J Alzheimers Dis Other Demen 19 (2004), 345-352.